🇺🇸 FDA
Pipeline program

Venclexta 100 MG Oral Tablet

2022-SR-541

Unknown small_molecule active

Quick answer

Venclexta 100 MG Oral Tablet for Acute Myeloid Leukemia is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Acute Myeloid Leukemia
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials